Latest Share Registry News

Domino’s Pizza Enterprises has explained the late filing of a director interest notice as an administrative oversight, reaffirming its compliance procedures amid ASX scrutiny.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW while acquiring promising US assets, enhancing its exploration pipeline with minimal upfront costs.

Cosmos Exploration progresses its exclusive option to acquire EAU Lithium, advancing lithium extraction technology testing in Bolivia’s high-magnesium brines with promising initial results.

Alicanto Minerals is actively assessing new copper, gold, and silver projects while preparing for a key summer field program in Sweden, supported by a solid cash position of $2.64 million.

Rio Tinto Limited has announced a fully franked interim dividend of USD 1.48 per share for the six months ending June 2025, with multiple currency payment options and a Dividend Reinvestment Plan available.

Vintage Energy has addressed an ASX compliance issue related to the timing of its May 2025 securities issuance, confirming reliance on its placement capacities to maintain regulatory adherence.

Kinterra Capital GP Corp. II has increased its takeover offer for New World Resources Limited to A$0.062 per share, presenting shareholders with a superior all-cash proposal compared to rival Central Asia Metals Plc. The offer, backed by Kinterra’s 19.3% stake, aims for full ownership and potential delisting of NWR.

Ryder Capital has halted its Dividend Reinvestment Plan, opting to pay shareholders cash dividends instead. The move raises questions about the company’s strategic direction and shareholder returns.

PointsBet Holdings has dismissed allegations from Betr Entertainment regarding vote exclusion in its recent Scheme of Arrangement meeting, confirming the scheme’s approval and setting the stage for a crucial court hearing.

Australian Strategic Materials Limited (ASM) has announced an underwritten Share Purchase Plan to raise approximately A$3 million, offering eligible shareholders a 20% discount on new shares. The plan opens on 19 June and closes on 17 July 2025.

Artrya Limited has submitted a pivotal FDA 510(k) application for its AI-powered Salix® Coronary Plaque module, aiming for clearance in Q3 2025 and a lucrative US commercial launch.

AdAlta Limited has successfully placed the remaining shortfall in its renounceable rights issue, raising a total of $1.3 million to advance its cellular immunotherapy pipeline. The company also addressed an administrative breach involving director share allocations, ensuring compliance with ASX rules.